<p>Groups of 6 female BALB/c mice were immunized 3 times (s.c.) with 10 µg of protein in the following adjuvant formulations: Alum, FliC, CpG ODN 1826, Quil A, TiterMax, or IFA. Anti-PvMSP-3α in the sera of immunized mice was analyzed by ELISA 2 weeks after the first (<b>A</b>), second (<b>B</b>), and third (<b>C</b>) immunizing dose. Results are expressed as mean IgG antibody titers (log<sub>10</sub>) ± SEM and were compared by one-way ANOVA followed by Tukey’s test for multiple comparisons. Significant differences are noted on the graph: *<i>p</i><0.05; **<i>p</i><0.01; ***<i>p</i><0.001. Non-significant (n.s.) differences are indicated (<i>p</i>>0.05). Data representative of 2 independent experiments.</p
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>3-week old A/J mice were immunized with PA-Av/IFA (○), PA-Av-Alum (□), or PA-Av-C3d<sub>3</sub>/I...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>BALB/c mice were immunized with recombinant PvMSP-3β in the presence of adjuvant as described in ...
<p>Groups of 5 mice were immunized 3 times (s.c.) with 10 µg of PvMSP-3α, PvMSP-3β (FP-1), PvMSP-3β ...
<p>129sv/ew mice were immunized with β-Gal alone or with adjuvant, as indicated. Three different dos...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>Groups of five female BALB/c mice were sequentially immunized with VSV*ΔG(MUL2232) (A) or VSV*Δ(M...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
Both IgG1 and IgG2a-specific antibody titres in mice immunized with four different antigens are comp...
<p>129sv/ew (A) or BALB/c (B) mice were immunized with the indicated regimen. Doses used were: 10<su...
<p>Immunogenicity in three mouse species (NIH, Balb/c, C57/Black), analyzed by ELISA measuring total...
<p>Groups of five BALB/c mice were immunized three times in three week intervals with 20 μg of rMUL2...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>3-week old A/J mice were immunized with PA-Av/IFA (○), PA-Av-Alum (□), or PA-Av-C3d<sub>3</sub>/I...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>BALB/c mice were immunized with recombinant PvMSP-3β in the presence of adjuvant as described in ...
<p>Groups of 5 mice were immunized 3 times (s.c.) with 10 µg of PvMSP-3α, PvMSP-3β (FP-1), PvMSP-3β ...
<p>129sv/ew mice were immunized with β-Gal alone or with adjuvant, as indicated. Three different dos...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>Groups of five female BALB/c mice were sequentially immunized with VSV*ΔG(MUL2232) (A) or VSV*Δ(M...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
Both IgG1 and IgG2a-specific antibody titres in mice immunized with four different antigens are comp...
<p>129sv/ew (A) or BALB/c (B) mice were immunized with the indicated regimen. Doses used were: 10<su...
<p>Immunogenicity in three mouse species (NIH, Balb/c, C57/Black), analyzed by ELISA measuring total...
<p>Groups of five BALB/c mice were immunized three times in three week intervals with 20 μg of rMUL2...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>3-week old A/J mice were immunized with PA-Av/IFA (○), PA-Av-Alum (□), or PA-Av-C3d<sub>3</sub>/I...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...